Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Clasificación en acciones #27024
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Precio por acción
$0.16240909
Última sincronización: 2025-03-04
Capitalización bursátil
$35.68M
Cambio (1 día)
0.27%
Cambio (1 año)
0.00%
País
CN
Comercio Dali Pharmaceuticalco.,Ltd (603963)

Categoría

Historial de rendimiento por dividendo de Dali Pharmaceuticalco.,Ltd (603963)
Rendimiento por dividendo (TTM) de Dali Pharmaceuticalco.,Ltd (símbolo bursátil: 603963) al 2022-12-31: 0.08%
Rendimiento promedio por dividendo de los últimos 5 años: 0.24%
Historial de rendimiento por dividendo de Dali Pharmaceuticalco.,Ltd (603963) desde 2012 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
2026 (TTM) 0.00% -100.00%
2023 0.06% -25.00%
2022 0.08% -84.62%
2021 0.52% 1,633.33%
2020 0.03% -94.23%
2019 0.52% -21.21%
2018 0.66% -76.00%
2017 2.75% -59.80%
2016 6.84% -18.18%
2015 8.36% -14.69%
2014 9.80% 15.70%
2013 8.47% 9,311.11%
2012 0.09% 0.00%
Rendimientos por dividendo (TTM) de empresas similares o competidoras